Abstract
Earlier experience with micafungin demonstrated a successful outcome in treating pulmonary aspergillosis in leukemic patients. We report a case of renal transplant recipient (RTR) who developed disseminated invasive aspergillosis. The patient was treated with micafungin with complete clinical and radiological response.
MeSH terms
-
Antifungal Agents / therapeutic use*
-
Echinocandins / therapeutic use*
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Invasive Pulmonary Aspergillosis / diagnosis
-
Invasive Pulmonary Aspergillosis / drug therapy*
-
Invasive Pulmonary Aspergillosis / etiology
-
Kidney Transplantation / adverse effects*
-
Lipopeptides / therapeutic use*
-
Male
-
Micafungin
-
Middle Aged
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antifungal Agents
-
Echinocandins
-
Immunosuppressive Agents
-
Lipopeptides
-
Micafungin